September 20, 2018 Significantly more people are surviving end-stage renal (kidney) disease caused by lupus nephritis according to a long-term analysis published in Arthritis & Rheumatology. The analysis of the national registry of 20,974 patients with end-stage renal disease (ESRD) during the years 1995 through 2014 found that mortality rates significantly declined. In addition, among […] READ MORE
The Lupus Research Alliance celebrates our annual Breaking through Lupus Gala on November 19, 2018 at the Ziegfeld Ballroom – an iconic landmark mingling up-to-the-moment elegance with the art-deco grandeur of 1920’s movie palaces. This year we are proud to honor William J. Wolfe, Chairman and Chief Executive Officer of First Washington Realty, Inc. A […] READ MORE
September 14, 2018 Congratulations are in order for lupus advocacy! The two budget requests Lupus Research Alliance advocates worked so hard for to fund lupus research were included in the budget appropriations bill released last night by Congress. Last week, the Lupus Research Alliance wrote to the legislators working on final language to request that […] READ MORE
September 7, 2018 We congratulate Dr. Betty Diamond of Feinstein Institute for Medical Research for her recently published work showing that ACE inhibitors, a specific type of hypertension drugs approved for lowering high blood pressure may prevent memory loss for people with lupus. With her 2018 Lupus Insight Prize from the Lupus Research Alliance, Dr. Diamond […] READ MORE
Data from a long-term Black Women’s Health Study of 59,000 Black women found that cigarette smoking raised the risk for lupus, but not significantly compared with those who had never smoked. In contrast, the incidence of lupus was significantly lower among Black women who drank moderately which was defined as greater or equal to four […] READ MORE
Sept. 5, 2018 Our microbiome includes all of the trillions of microorganisms that live in and on us. A recent review article about key discoveries on the role of the microbiome in lupus includes two researchers funded by the Lupus Research Alliance who may have discovered how some of these microbial passengers promote lupus by […] READ MORE
September 4, 2018 The Lupus Research Alliance is disappointed with the results announced by AstraZeneca and MedImmune of the clinical trial testing the investigational drug anifrolumab for moderate to severe systemic lupus erythematosus (SLE). However, the knowledge gained from further analyzing these data will be invaluable in fully understanding the effects of anifrolumab and designing […] READ MORE
August 28, 2018 The Lupus Research Alliance was proud to take part in the NY Jets 2018 KickOff Luncheon that launched the upcoming season while gaining awareness for the worthwhile causes supported by the team. With the help of nearly 800 generous supporters, the luncheon raised over $750,000 to benefit the Lupus Research Alliance along […] READ MORE
August 28, 2018 NEW YORK, NY. Aker BioMarine and Lupus Research Alliance launch a new clinical study, investigating how phospholipid-rich krill oil can benefit people with lupus, with the aim to lessen the severity of symptoms associated with the disease. Affecting an estimated 5 million people worldwide, Systemic Lupus Erythematosus (SLE), better known as lupus, […] READ MORE
August 22, 2018 The Lupus Research Alliance is proud to once again be awarded the Health Grant from the Hearst Foundations. In the amount of $150,000, the highly sought Health Grant will help support two promising investigators relatively new to lupus who were recently awarded our Novel Research Grants, Drs. Andrea Knight and Vipin Kumar. […] READ MORE
August 24, 2018 The U.S. Senate voted 85 to 7 to approve the $2 billion budget increase Lupus Research Alliance advocates requested for medical research funded by the National Institutes of Health (NIH). This increase of 5.4 percent would bring the budget for the NIH up to $39,084,000,000. Per today’s vote, the Labor, Health and […] READ MORE
August 20, 2018 Source: CareFirst BlueCross BlueShield Press Release CareFirst BlueCross BlueShield (CareFirst) and Exagen Diagnostics, Inc. (Exagen) today announced an agreement to collaborate to study the impact of Exagen’s proprietary AVISE Lupus test. As part of the agreement, select CareFirst members will have access to the AVISE Lupus test to aid in the differential […] READ MORE
